SPAG5 and cancer: The prevalent gene gains and amplifications of SPAG5 facilitate neoplastic growth, chemoresistance, metastasis, local recurrence, and overall survival (OS), whereas downregulated SPAG5 expression in several cancer cell models impairs cell proliferation and migration motility and resensitises cells to anticancer therapy [4,5,6,7,8,9].